In The News

Lithium, brain imaging, & the future of Alzheimer’s treatment with Alzamend CEO Stephan Jackman

Phyllis Ayman of Senior Nation speaks with Stephan Jackman

Q&A: Head coil aims to assist treatment for Alzheimer’s, bipolar, PTSD, depression

Stephan Jackman of Alzamend Neuro: The CEO With a Two-Pronged Attack on Alzheimer’s and Mental Health Disorders

Altasciences Completes Clinical Portion of Alzamend Neuro’s Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer’s

Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia

CEO Stephan Jackman interviewed on Fox Business News

Alzamend Neuro aiming to rapidly develop and market safe and effective treatments for Alzheimer's

Alzamend Neuro Stock Pops After Benzinga Exclusive On Cognition Therapeutics Alzheimer's Data

FDA provides guidance to Alzamend ahead of IND application for oral therapeutic